Medytox Inc. (CEO Hyun Ho Jung), a biopharmaceutical company, announced on the 24th that it retained a global law firm ‘Quinn Emanuel’ to protect its intellectual property rights such as botulinum strains and manufacturing processes. QE plans to actively push ahead with necessary actions to regain Medytox’s legitimate rights from all companies seeking overseas business by infringing Medytox's intellectual property rights.

QE, one of the world class law firms related to IP protection, is a leading law firm that specializes in dispute cases such as litigation and international arbitration. In particular, QE obtained favorable outcomes when it represented Samsung Electronics in the international ‘smartphone war’ between Samsung and Apple as well as Samsung and Huawei, and also led Mirae Asset to a complete victory in a U.S. lawsuit filed by a large Chinese insurance company.

QE is famous as a law firm in the world that major companies least want to see as opposing counsel. According to an interview conducted by the BTI Consulting Group in 2020 with more than 300 global companies with more than $1 billion in annual revenue, QE ranked as ‘the number one law firm they are feared the most to fight against.’

A Medytox official stated, “The reason and justification for protecting Medytox's intellectual property rights have been clearly established by the recent successful U.S. ITC lawsuit,” and “Medytox should protect its IP right against companies that are seeking overseas business by infringing on such rights. And by retaining the global law firm ‘Quinn Emanuel,’ Medytox will actively pursue its legitimate rights.”

John Quinn, the founder of QE, stated that “We are honored to be representing Medytox in connection with the protection of its IP rights. Having carefully reviewed the facts pertaining to Medytox’s IP rights, Quinn Emanuel intends to vigorously defend such rights against all infringing parties.”